BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 16190134)

  • 1. Clinical and epidemiological implications of meningococcal disease.
    Meredith ; Galwankar S
    J Assoc Physicians India; 2005 Jul; 53():628-33. PubMed ID: 16190134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal disease.
    Rosenstein NE; Perkins BA; Stephens DS; Popovic T; Hughes JM
    N Engl J Med; 2001 May; 344(18):1378-88. PubMed ID: 11333996
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
    Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
    Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
    Holst J; Martin D; Arnold R; Huergo CC; Oster P; O'Hallahan J; Rosenqvist E
    Vaccine; 2009 Jun; 27 Suppl 2():B3-12. PubMed ID: 19481313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningococcal disease--outbreak in Delhi.
    Sachdeva A; Kukreja S; Jain V; Dutta AK
    Indian Pediatr; 2005 Jun; 42(6):547-56. PubMed ID: 15995271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in meningococcal epidemiology and current vaccine recommendations.
    Baltimore RS
    Curr Opin Pediatr; 2006 Feb; 18(1):58-63. PubMed ID: 16470164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal disease and prevention at the Hajj.
    Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):219-25. PubMed ID: 19717104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing meningococcal infection in college students.
    Harrison LH
    Clin Infect Dis; 2000 Apr; 30(4):648-51. PubMed ID: 10770724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass antibiotic treatment to stop an outbreak of meningococcal disease: a molecular analysis.
    Katz LH; Zelazny A; Scharf S; Hourvitz A; Asor N; Arbeli Y; Yust-Katz S; Smollan-Fredman G; Gdalevich M
    Clin Microbiol Infect; 2007 Sep; 13(9):943-6. PubMed ID: 17635531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outbreaks of group B meningococcal disease--Florida, 1995 and 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(39):833-7. PubMed ID: 9780239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. History of meningococcal vaccines and their serological correlates of protection.
    Vipond C; Care R; Feavers IM
    Vaccine; 2012 May; 30 Suppl 2():B10-7. PubMed ID: 22607894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease.
    Caugant DA
    Infect Genet Evol; 2008 Sep; 8(5):558-65. PubMed ID: 18479979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology and control of invasive meningococcal disease.
    Diaz PS
    Pediatr Infect Dis J; 1999 Jul; 18(7):633-4. PubMed ID: 10440442
    [No Abstract]   [Full Text] [Related]  

  • 15. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.
    Can Commun Dis Rep; 2007 Jun; 33(10):1-15. PubMed ID: 17691125
    [No Abstract]   [Full Text] [Related]  

  • 17. The meningococcal vaccine--public policy and individual choices.
    Offit PA; Peter G
    N Engl J Med; 2003 Dec; 349(24):2353-6. PubMed ID: 14668463
    [No Abstract]   [Full Text] [Related]  

  • 18. Invasive infections caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae among children in St Petersburg, Russia.
    Kaijalainen T; Kharit SM; Kvetnaya AS; Sirkiä K; Herva E; Parkov OV; Nohynek H
    Clin Microbiol Infect; 2008 May; 14(5):507-10. PubMed ID: 18318743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.
    Brooks R; Woods CW; Benjamin DK; Rosenstein NE
    Clin Infect Dis; 2006 Jul; 43(1):49-54. PubMed ID: 16758417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of meningococcal disease.
    Kimmel SR
    Am Fam Physician; 2005 Nov; 72(10):2049-56. PubMed ID: 16342836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.